Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5075251
Max Phase: Preclinical
Molecular Formula: C24H28N2O2
Molecular Weight: 376.50
Molecule Type: Unknown
Associated Items:
ID: ALA5075251
Max Phase: Preclinical
Molecular Formula: C24H28N2O2
Molecular Weight: 376.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C1[C@@H]2CCC[C@@]1(COC(=O)c1ccccc1-c1ccccn1)CN(CC)C2
Standard InChI: InChI=1S/C24H28N2O2/c1-3-26-15-19-9-8-13-24(16-26,18(19)2)17-28-23(27)21-11-5-4-10-20(21)22-12-6-7-14-25-22/h4-7,10-12,14,19H,2-3,8-9,13,15-17H2,1H3/t19-,24+/m1/s1
Standard InChI Key: OEGRZDYKBXWJKY-DVECYGJZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 376.50 | Molecular Weight (Monoisotopic): 376.2151 | AlogP: 4.58 | #Rotatable Bonds: 5 |
Polar Surface Area: 42.43 | Molecular Species: BASE | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.74 | CX LogP: 4.46 | CX LogD: 3.10 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.57 | Np Likeness Score: -0.07 |
1. Gallagher R, Qudah T, Balle T, Chebib M, McLeod MD.. (2021) Novel methyllycaconitine analogues selective for the α4β2 over α7 nicotinic acetylcholine receptors., 51 [PMID:34798380] [10.1016/j.bmc.2021.116516] |
Source(1):